L
Lydia Doan
Researcher at University of Nevada, Reno
Publications - 5
Citations - 64
Lydia Doan is an academic researcher from University of Nevada, Reno. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 2, co-authored 2 publications receiving 21 citations.
Papers
More filters
Journal ArticleDOI
Host plant associated enhancement of immunity and survival in virus infected caterpillars
Angela M. Smilanich,Tara C. Langus,Lydia Doan,Lee A. Dyer,Joshua G. Harrison,Jennifer Hsueh,Mike B. Teglas +6 more
TL;DR: Results suggest that plant secondary metabolites are important for survival against a viral pathogen and may be associated with activation of PO.
Journal ArticleDOI
An arthropod survival strategy in a frequently burned forest
TL;DR: It is suggested that tiny, yet highly sensitive, sensory adaptations may aid in an interesting arthropod behavior that takes place before the fire arrives: insect ears.
Journal ArticleDOI
Honeysuckle (Lonicera japonica) and Huangqi (Astragalus membranaceus) Suppress SARS-CoV-2 Entry and COVID-19 Related Cytokine Storm in Vitro
Yuan-Chieh Yeh,Lydia Doan,Zi-Yi Huang,Li Wei Chu,Tzu Hau Shi,Ying-Ray Lee,Cheng-Tao Wu,Chaofeng Lin,Shu-Tuan Chiang,Hui-Kang Liu,Tsung-Hsien Chuang,Yueh-Hsin Ping,Hsiao Sheng Liu,Chi-Ping Huang +13 more
TL;DR: It is demonstrated that honeysuckle and Huangqi have the potential to be used as an inhibitor of SARS-CoV-2 virus entry that warrants further in vivo analysis and functional assessment of miRNAs to confirm their clinical importance.
Journal ArticleDOI
Virofree, an Herbal Medicine-Based Formula, Interrupts the Viral Infection of Delta and Omicron Variants of SARS-CoV-2
Lydia Doan,Li Wei Chu,Zi-Yi Huang,Anh Nguyen,Chien-Ping Lee,Chien-Ling Huang,Yu-Fen Chang,Wen-Yu Hsieh,Trang Nguyen,Chaofeng Lin,Chun-Yi Su,Tsung-Hsien Chuang,Jin-Mei Lai,Feng Wang,Chia-Jui Yang,Hui-Kang Liu,Yueh-Hsin Ping,Chi-Ping Huang +17 more
TL;DR: The inhibitory effect of Virofree was repurposed as a potential herbal medicine to combat COVID-19 and highlighted the entry of Delta and Omicron variants of SARS-CoV-2, which have not had any effective treatments during the emergence of the new variants spreading.
Journal ArticleDOI
Repurposing Astragalus Polysaccharide PG2 for Inhibiting ACE2 and SARS-CoV-2 Spike Syncytial Formation and Anti-Inflammatory Effects
Chien-Ping Lee,Anh Nguyen,Lydia Doan,Li Wei Chu,Chih-Hung Chang,Hui-Kang Liu,I-Lin Lee,Teng-Hsu Wang,Jin-Mei Lai,Shih-Ming Tsao,Hsiu-Jung Liao,Yueh-Hsin Ping,Chi-Ying F. Huang +12 more
TL;DR: Astragalus polysaccharide (PG2) as discussed by the authors is a repurposed drug that possesses the potential to prevent WT SARS-CoV-2 S-mediated syncytia formation with the host cells; it also inhibits the binding of S proteins of WT, alpha, and beta strains to the recombinant ACE2 and halts severe COVID-19 development by regulating the polarization of macrophages to M2 cells.